A share price of CME Group Inc [CME] is currently trading at $273.74, up 0.29%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The CME shares have gain 2.78% over the last week, with a monthly amount drifted -1.93%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
CME Group Inc [NASDAQ: CME] stock has seen the most recent analyst activity on October 23, 2025, when Deutsche Bank upgraded its rating to a Buy but kept the price target unchanged to $300 for it. Previously, Citigroup upgraded its rating to Buy on September 25, 2025, and kept the price target unchanged to $300. On July 24, 2025, downgrade downgraded it’s rating to Neutral but maintained its price target of $305 on the stock. Morgan Stanley upgraded its rating to an Overweight but stick to its price target of $301 on April 08, 2025. Raymond James upgraded its rating to an Outperform but $287 remained the price target by the analyst firm on March 10, 2025. Citigroup downgraded its rating to Neutral for this stock on January 06, 2025, and downed its price target to $250. In a note dated October 08, 2024, Redburn Atlantic downgraded a Neutral rating on this stock but restated the target price of $244.
CME Group Inc experienced fluctuations in its stock price throughout the past year between $224.62 and $290.79. Currently, Wall Street analysts expect the stock to reach $301 within the next 12 months. CME Group Inc [NASDAQ: CME] shares were valued at $273.74 at the most recent close of the market. An investor can expect a potential return of 9.96% based on the average CME price forecast.
Analyzing the CME fundamentals
Trailing Twelve Months sales for CME Group Inc [NASDAQ:CME] were 6.40B which represents -2.95% decline. Gross Profit Margin for this corporation currently stands at 0.86% with Operating Profit Margin at 0.65%, Pretax Profit Margin comes in at 0.76%, and Net Profit Margin reading is 0.59%. To continue investigating profitability, this company’s Return on Assets is posted at 0.02, Equity is 0.14 and Total Capital is 0.11. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.12.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 271.75 points at the first support level, and at 269.76 for the second support level. However, for the 1st resistance point, the stock is sitting at 276.12, and for the 2nd resistance point, it is at 278.49.
Ratios To Look Out For
To put it in perspective, the Current Ratio for CME Group Inc [NASDAQ:CME] is 1.02. In addition, the Quick Ratio stands at 1.02 and the Cash Ratio stands at 0.02. Considering the valuation of this stock, the price to sales ratio is 15.43, the price to book ratio is 3.49 and price to earnings (TTM) ratio is 26.53.
Transactions by insiders
Recent insider trading involved DUFFY TERRENCE A, Chairman and CEO, that happened on Dec 11 ’25 when 25000.0 shares were sold. officer, Terrence Duffy completed a deal on Dec 11 ’25 to buy 25000.0 shares. Meanwhile, Sr MD Gl Hd Commodities Mkts Sammann Derek sold 7200.0 shares on Nov 20 ’25.
